Similar content being viewed by others Introduction A progressive decline in skeletal muscle mass and strength, or sarcopenia, is increasingly recognized as a significant comorbidity in patients with type 2 diabetes mellitus (T2D) and obesity [1, 2]
There is no prior authorization, step therapy, or utilization management
[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Marso S.P., Daniels G.H., Brown-Frandsen K., et al
On the contrary, tirzepatide may help alleviate cardiopulmonary strain in OSAS patients by improving metabolic balance and systemic inflammation (54)
This question is keyand still evolving
Significant weight loss may influence hormonal balance and thermoregulation in some patients, though evidence suggests weight loss may actually improve vasomotor symptoms in overweight postmenopausal women